Grantham, Mayo, Van Otterloo & Co (GMO)
BATRK icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Atlanta Braves Holdings Series B BATRK Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio BATRK Stock Details BATRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-268,562
Closed -$3.94M – 518
2016
Q2 		$3.94M Buy
+268,562
New +$4M 0.02% 314

Other funds holding BATRK

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
FCP
Fine Capital Partners New York $563M AUM 7.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
EastBay Asset Management New York $27.9M AUM 37.2% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s BATRK Position: Q3 2016 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Atlanta Braves Holdings Series B (BATRK) in Q3 2016, closing a stake of 268,562 shares — an estimated $3.94M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in BATRK in Q2 2016 and held it in 1 quarter. The position peaked at $3.94M in Q2 2016. 184 funds tracked by Wall St. Rank hold BATRK as of Q3 2016.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Atlanta Braves Holdings Series B position as of Q3 2016 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 268,562 Atlanta Braves Holdings Series B shares in Q3 2016, an estimated $3.94M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Atlanta Braves Holdings Series B in Q2 2016 and held it in 1 quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Atlanta Braves Holdings Series B position peaked at $3.94M in Q2 2016.
  • 184 funds tracked by Wall St. Rank held Atlanta Braves Holdings Series B as of Q3 2016.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2016, filed 10 Nov 2016.